Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week

ÇEKMEN, Mustafa Baki; YILDIRIM KÖPÜK, Şule; YÜCESOY, Gülseren; Ceylan, Yasin; ÇAKIROĞLU, Yiğit

doi:10.4274/eamr.galenos.2018.27879

Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week

Şule YILDIRIM KÖPÜK, (Sağlık Bilimleri Üniversitesi)

Yiğit ÇAKIROĞLU, (Kocaeli Üniversitesi)

Yasin CEYLAN, (Mardin Kızıltepe Devlet Hastanesi)

Mustafa Baki ÇEKMEN, (Medeniyet Üniversitesi)

Gülseren YÜCESOY (Kocaeli Üniversitesi)

European Archives of Medical Research

4 0

Yıl: 2019 Cilt: 35 Sayı: 3 Sayfa Aralığı: 137 - 142 Metin Dili: İngilizce DOI: 10.4274/eamr.galenos.2018.27879 İndeks Tarihi: 02-04-2020

Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week

Öz:

Objective: We aimed to evaluate the prediction of preeclampsia by maternal serum pregnancy-associated plasma protein A (PAPP-A), placental growth factor (PIGF),sEndoglin (sEng) and uterine artery Doppler examination.Methods: One hundred and ninety-three singleton pregnant women admitted to outpatient clinic at 11-13+6 weeks for first trimester combined screening test wereincluded in the study. Maternal history was taken, and uterine artery Doppler examination and serum biomarker screening (PAPP-A, PIGF, sEndoglin) were conducted.The follow-up results of pregnancy were recorded. The study cohort was divided into two groups as “control” and “preeclampsia”. Mann-Whitney U and chi-square testswere used for comparison of independent variables. Sensitivity and specificity for the predictive values of the significant parameters were calculated from ROC curves.Results: Of 193 women, 168 women (87%) were in the control group (group 1) and 25 women (12.9%) who developed preeclampsia were defined in the preeclampsiagroup. In preeclampsia group, 20 women (10.3%) with gestational hypertension and mild preeclampsia were defined as “group 2”, and five women (2.5%) with severepreeclampsia and hemolysis, elevated liver enzymes, low platelet were defined as “group 3”. Maternal serum PAPP-A, PIGF, sEng levels were not significantly differentbetween preeclampsia group and control group, whereas uterine artery Doppler pulsatility index (PI) values were significantly higher in preeclampsia group (p=0.023).sEng levels were significantly higher in group 3 than those in group 2 (p=0.001). If uterine artery PI cut-off level was taken as >2.23 in ROC curve analysis, sensitivitywas 42.31% and specificity was 82.10% for detecting preeclampsia.Conclusion: Maternal serum PAPP-A, PIGF and sEng were not effective in predicting preeclampsia. However, these markers can be used to distinguish between mild andsevere preeclampsia. First trimester uterine artery Doppler examination is an effective screening method for predicting preeclampsia.

Anahtar Kelime:

Konular: Sağlık Bilimleri ve Hizmetleri

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77:67-75.
2. Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental development during the first trimester: implications for the pathophysiology of preeclampsia. Placenta 2000;21 Suppl A:25-30.
3. Gómez O, Figueras F, Martínez JM, del Río M, Palacio M, Eixarch E, et al. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 2006;28:802-8.
4. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011;31:66-74.
5. Baumann MU, Bersinger NA, Surbek DV. Serum markers for predicting preeclampsia. Mol Aspects Med 2007;28:227-44.
6. Chaiworapongsa T, Romero R, Tarca AL, Kusanovic JP, Gotsch F, Mittal P, et al. A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia. Am J Obstet Gynecol 2010;202:550.e1-10.
7. Luft FC. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a preeclampsia molecule. Nephrol Dial Transplant 2006;21:3052-4.
8. Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H. A Brief Overview of Preeclampsia. J Clin Med Res 2014;6:1-7.
9. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, et al. Association of extreme first trimester free human chorionic gonadotropinbeta, pregnancy associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004;191:1452-8.
10. Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. Predicting the risk of pre-eclampsia between 11 and 13 weeks’ gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG. Prenat Diagn 2010;30:1138-42.
11. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122-31.
12. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172:125-9.
13. Harrington K, Carpenter RG, Goldfrad C, Campbell S. Transvaginal Doppler ultrasound of the uteroplacental circulation in the early prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1997;104:674-81.
14. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia. Ultrasound Obstet Gynecol 2008;32:133-7.
15. Napolitano R, Melchiorre K, Arcangeli T, Dias T, Bhide A, Thilaganathan B. Screening for preeclampsia by using changes in uterine artery Doppler indices with advancing gestation. Prenat Diagn 2012;32:180-4.
16. Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006;27:13-7.
17. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009;33:23-33.
18. Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007;29:128- 34.
19. Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Vecchi Brumatti L, et al. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 2012;33:495-501.
20. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005;25:949-53.
21. Lai J, Syngelaki A, Poon LC, Nucci M, Nicolaides KH. Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia. Fetal Diagn Ther 2013;33:149-55.
22. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009;22:1021-38.
23. Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005;293:77-85.
24. Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013;33:8-15.
25. Diguisto C, Piver E, Gouge AL, Eboue F, Vaillant CL, Maréchaud M, et al. First trimester uterine artery Doppler, sFlt-1 and PlGF to predict preeclampsia in a high-risk population. J Matern Fetal Neonatal Med 2017;30:1514-9.
26. Li L, Zheng Y, Zhu Y, Li J. Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia. Exp Ther Med 2016;12:2515-20.
27. O’Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol 2017;49:751-755.
28. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-8.

APA	YILDIRIM KÖPÜK Ş, ÇAKIROĞLU Y, Ceylan Y, ÇEKMEN M, YÜCESOY G (2019). Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. , 137 - 142. 10.4274/eamr.galenos.2018.27879
Chicago	YILDIRIM KÖPÜK Şule,ÇAKIROĞLU Yiğit,Ceylan Yasin,ÇEKMEN Mustafa Baki,YÜCESOY Gülseren Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. (2019): 137 - 142. 10.4274/eamr.galenos.2018.27879
MLA	YILDIRIM KÖPÜK Şule,ÇAKIROĞLU Yiğit,Ceylan Yasin,ÇEKMEN Mustafa Baki,YÜCESOY Gülseren Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. , 2019, ss.137 - 142. 10.4274/eamr.galenos.2018.27879
AMA	YILDIRIM KÖPÜK Ş,ÇAKIROĞLU Y,Ceylan Y,ÇEKMEN M,YÜCESOY G Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. . 2019; 137 - 142. 10.4274/eamr.galenos.2018.27879
Vancouver	YILDIRIM KÖPÜK Ş,ÇAKIROĞLU Y,Ceylan Y,ÇEKMEN M,YÜCESOY G Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. . 2019; 137 - 142. 10.4274/eamr.galenos.2018.27879
IEEE	YILDIRIM KÖPÜK Ş,ÇAKIROĞLU Y,Ceylan Y,ÇEKMEN M,YÜCESOY G "Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week." , ss.137 - 142, 2019. 10.4274/eamr.galenos.2018.27879
ISNAD	YILDIRIM KÖPÜK, Şule vd. "Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week". (2019), 137-142. https://doi.org/10.4274/eamr.galenos.2018.27879

APA	YILDIRIM KÖPÜK Ş, ÇAKIROĞLU Y, Ceylan Y, ÇEKMEN M, YÜCESOY G (2019). Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. European Archives of Medical Research, 35(3), 137 - 142. 10.4274/eamr.galenos.2018.27879
Chicago	YILDIRIM KÖPÜK Şule,ÇAKIROĞLU Yiğit,Ceylan Yasin,ÇEKMEN Mustafa Baki,YÜCESOY Gülseren Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. European Archives of Medical Research 35, no.3 (2019): 137 - 142. 10.4274/eamr.galenos.2018.27879
MLA	YILDIRIM KÖPÜK Şule,ÇAKIROĞLU Yiğit,Ceylan Yasin,ÇEKMEN Mustafa Baki,YÜCESOY Gülseren Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. European Archives of Medical Research, vol.35, no.3, 2019, ss.137 - 142. 10.4274/eamr.galenos.2018.27879
AMA	YILDIRIM KÖPÜK Ş,ÇAKIROĞLU Y,Ceylan Y,ÇEKMEN M,YÜCESOY G Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. European Archives of Medical Research. 2019; 35(3): 137 - 142. 10.4274/eamr.galenos.2018.27879
Vancouver	YILDIRIM KÖPÜK Ş,ÇAKIROĞLU Y,Ceylan Y,ÇEKMEN M,YÜCESOY G Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week. European Archives of Medical Research. 2019; 35(3): 137 - 142. 10.4274/eamr.galenos.2018.27879
IEEE	YILDIRIM KÖPÜK Ş,ÇAKIROĞLU Y,Ceylan Y,ÇEKMEN M,YÜCESOY G "Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week." European Archives of Medical Research, 35, ss.137 - 142, 2019. 10.4274/eamr.galenos.2018.27879
ISNAD	YILDIRIM KÖPÜK, Şule vd. "Prediction of Preeclampsia by Uterine Artery Doppler Examination and Placental Growth Factor, Endoglin and Pregnancy-associated Plasma Protein Levels in Maternal Serum at 11-13+6 Pregnancy Week". European Archives of Medical Research 35/3 (2019), 137-142. https://doi.org/10.4274/eamr.galenos.2018.27879